-
EnGeneIC launches groundbreaking new Australian trial for innovative cancer therapy, with international trial site in Singapore to follow
13 May 2025 02:00 GMT
… in patients with advanced solid tumours expressing Epidermal Growth Factor Receptor … small cell lung cancer (NSCLC), mesothelioma, kidney and bladder cancer, pancreatic cancer, head and … a complete orchestra of anti-tumor responses, individual to every patient …
-
Northern BC clinical cancer trial gets funding boost from Wheelin' Warriors
11 May 2025 20:10 GMT
… of radiation to the tumour site, while limiting doses … will have breast cancer or lung cancer or kidney cancer and it has … who has breast cancer or prostate cancer get cured because … or reducing the tumors.
“SABR destroys cancer cells and cancer DNA at the …
-
Ionctura Commences Randomized Phase I/II Study In Non-Small Cell Lung Cancer
08 May 2025 09:18 GMT
… cell lung cancer (NSCLC).
NSCLC is the most common type of lung cancer. Lung cancer is … and may show synergistic anti-tumor immune activity without significant addition … for certain patients with dMMR tumours that have progressed on or …
-
Rewrite The APPLE’s core question—upfront osimertinib versus the sequential approach for EGFR mutated non-small cell lung cancer this news headline for the science magazine post
06 May 2025 19:42 GMT
… as the relationship between circulating tumour (ct)DNA and progression … patients may still have tumours which remain dependent on … lung cancer patientsbrain metastasis control in lung cancercirculating tumor DNA and PFSEGFR mutations in lung cancerfirst- …
-
lncSLERT Promotes Liver Metastasis in Colorectal Cancer by Down-Regulating HUNK Expression via RBM15-Mediated m6A Modification
09 May 2025 10:20 GMT
… a complex, multistep process involving tumor cell invasion, intravasation, survival in … from colorectal cancer: pathogenetic development, immune landscape of the tumour microenvironment … of m6A RNA methylation in lung cancer: from mechanism to prognosis and …
-
Clinical Significance of the Serum 3′tRF-AlaAGC, Neutrophil to High-Density Lipoprotein Ratio, and Lymphocyte-to-Monocyte Ratio in Breast Cancer with Lymph Node Metastasis
07 May 2025 15:05 GMT
… overexpressed in non-small cell lung cancer (NSCLC) patients and related … linked to different stages of tumorigenesis, proliferation, invasion, metastasis, and … et al. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms …
-
Immutep’s Efti in Combination with KEYTRUDA® (pembrolizumab) Drives Strong Overall Survival in Head and Neck Cancer with CPS <1
05 May 2025 12:00 GMT
… head and neck cancer patients with such cold tumors. Combining these two … 1L HNSCC patients with cold tumors and PD-L1 CPS … variety of solid tumours including non-small cell lung cancer (NSCLC), head and …
-
A Bi2O3-TiO2 Heterojunction for Triple-Modality Cancer Theranostics
29 Apr 2025 15:30 GMT
… radiosensitization effectively damaged tumors and inhibited cellular proliferation … tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer … radiotherapy and immunotherapy in lung cancer: can we expect limitations …
-
Efficacy of a Neuroimmune Therapy Including Pineal Methoxyindoles, Angiotensin 1-7, and Endocannabinoids in Cancer, Autoimmune, and Neurodegenerative Diseases
29 Apr 2025 07:40 GMT
… of cancer, including glioma, breast cancer, and small cell lung cancer. LMR … product known for its inflammatory, tumor-promoting, immunosuppressive, hypertensive, cardiotoxic … Health Organization. WHO classification of tumours online. Available from: https …
-
Bacteria-Assisted Celastrol Liposomes for Effective Chemotherapy Against Lung Cancer in Mice Model
14 Apr 2025 14:59 GMT
… in various mouse models of tumors, including lung cancer,10 hepatocellular carcinoma,11 … celastrol in lung cancer treatment. The growth and spread of tumor cells … Targeting the tumour vasculature: insights from physiological angiogenesis. Nat Rev Cancer. 2010 …
About
© 1995-2025